14 assets in Trigeminal Neuralgia

Therapeutic assets addressing Trigeminal Neuralgia, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Neurotop Trigeminal Neuralgia	Beijing Tiantan Hospital	P4	BB (71)
Oxcarbazepine Trigeminal Neuralgia	Abbasi Shaheed Hospital	P4	B (63)
Vixotrigine Trigeminal Neuralgia	Biogen	P3	B (62)
Gabapentine Trigeminal Neuralgia	Rehman Medical Institute - RMI	P2/3	B (61)
Basimglurant Trigeminal Neuralgia	Noema Pharma AG	P2/3	B (57)
Nucleo Cmp Forte Trigeminal Neuralgia	Karbala University	P2	B (57)
sr750 Trigeminal Neuralgia	Shanghai SIMR Biotechnology Co., Ltd.	P2	B (57)
rp-008 Trigeminal Neuralgia	Kriya Therapeutics, Inc.	P1/2	CC (47)
Varenicline Trigeminal Neuralgia	Kriya Therapeutics, Inc.	P1/2	CC (47)
Alloex Trigeminal Neuralgia	The Foundation for Orthopaedics and Regenerative Medicine	P1	CC (43)
Celecoxib Trigeminal Neuralgia	Beijing Tiantan Hospital	N/A	D (30)
Gerpevir Trigeminal Neuralgia	Beijing Tiantan Hospital	N/A	D (30)
Pregabalin Trigeminal Neuralgia	Postgraduate Institute of Dental Sciences Rohtak	N/A	D (30)